BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27058711)

  • 1. Intrapleural Fibrinolytic Therapy in Patients With Nondraining Indwelling Pleural Catheters.
    Vial MR; Ost DE; Eapen GA; Jimenez CA; Morice RC; O'Connell O; Grosu HB
    J Bronchology Interv Pulmonol; 2016 Apr; 23(2):98-105. PubMed ID: 27058711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Intrapleural Thrombolytic or Fibrinolytic Therapy, or Both, via Indwelling Tunneled Pleural Catheters With or Without Concurrent Anticoagulation Use.
    Gilbert CR; Wilshire CL; Chang SC; Gorden JA
    Chest; 2021 Aug; 160(2):776-783. PubMed ID: 33745991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapleural Fibrinolysis for the Treatment of Indwelling Pleural Catheter-Related Symptomatic Loculations: A Multicenter Observational Study.
    Thomas R; Piccolo F; Miller D; MacEachern PR; Chee AC; Huseini T; Yarmus L; Bhatnagar R; Lee HJ; Feller-Kopman D; Maskell NA; Tremblay A; Lee YCG
    Chest; 2015 Sep; 148(3):746-751. PubMed ID: 25742001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination Tissue Plasminogen Activator and DNase for Loculated Malignant Pleural Effusions: A Single-center Retrospective Review.
    Chan C; Sekowski V; Zheng B; Li P; Stollery D; Veenstra J; Gillson AM
    J Bronchology Interv Pulmonol; 2023 Jul; 30(3):238-243. PubMed ID: 35698287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapleural Fibrinolytics and Deoxyribonuclease for Treatment of Indwelling Pleural Catheter-Related Pleural Infection: A Multi-Center Observational Study.
    Fitzgerald DB; Muruganandan S; Tsim S; Ip H; Asciak R; Walker S; Uribe Becerra JP; Majid A; Ahmed L; Rahman NM; Maskell NA; Blyth KG; Lee YCG
    Respiration; 2021; 100(5):452-460. PubMed ID: 33784710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Pleural Space Infections in Patients With Indwelling Pleural Catheters for Active Malignancies.
    Chang CH; Ost DE; Jimenez CA; Saltijeral SN; Eapen GA; Casal RF; Sabath BF; Lin J; Cerrillos E; Nevarez Tinoco T; Grosu HB
    J Bronchology Interv Pulmonol; 2024 Apr; 31(2):155-159. PubMed ID: 37982602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
    Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
    Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive intrapleural tissue plasminogen activator administered via chest tubes placed with imaging guidance: effectiveness and risk for hemorrhage.
    Gervais DA; Levis DA; Hahn PF; Uppot RN; Arellano RS; Mueller PR
    Radiology; 2008 Mar; 246(3):956-63. PubMed ID: 18309017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of a complex malignant pleural effusion with 1 mg alteplase instilled through a non-draining indwelling pleural catheter.
    Nik Abeed NN; Faisal M; Ng BH; Ban Yu-Lin A
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33608330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.
    Popowicz N; Bintcliffe O; De Fonseka D; Blyth KG; Smith NA; Piccolo F; Martin G; Wong D; Edey A; Maskell N; Lee YCG
    Ann Am Thorac Soc; 2017 Jun; 14(6):929-936. PubMed ID: 28324671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection. A Single-Center Experience.
    Majid A; Kheir F; Folch A; Fernandez-Bussy S; Chatterji S; Maskey A; Fashjian M; Cheng G; Ochoa S; Alape D; Folch E
    Ann Am Thorac Soc; 2016 Sep; 13(9):1512-8. PubMed ID: 27333122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very low-dose intrapleural tPA for indwelling pleural catheter-associated symptomatic fluid loculation.
    Lan NSH; Vekaria S; Sidhu C; Lee YCG
    Respirol Case Rep; 2019 Oct; 7(7):e00457. PubMed ID: 31312455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of hemothorax secondary to intrapleural fibrinolytic therapy: Considerations for use of fibrinolytics in high-risk patients.
    Narula N; Katyal N; Salem M; Avula A; Siddiqui A; Maroun R; Chalhoub M
    Respir Med Case Rep; 2021; 34():101420. PubMed ID: 34354918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent Versus Sequential Intrapleural Instillation of Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection.
    Kheir F; Cheng G; Rivera E; Folch A; Folch E; Fernandez-Bussy S; Keyes C; Parikh M; Channick C; Chee A; Majid A
    J Bronchology Interv Pulmonol; 2018 Apr; 25(2):125-131. PubMed ID: 29346247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapleural tissue plasminogen activator for complicated pleural effusions.
    Skeete DA; Rutherford EJ; Schlidt SA; Abrams JE; Parker LA; Rich PB
    J Trauma; 2004 Dec; 57(6):1178-83. PubMed ID: 15625447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapleural urokinase for the treatment of loculated malignant pleural effusions and trapped lungs in medically inoperable cancer patients.
    Hsu LH; Soong TC; Feng AC; Liu MC
    J Thorac Oncol; 2006 Jun; 1(5):460-7. PubMed ID: 17409900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting tissue plasminogen activator use and success in in-center hemodialysis patients.
    Kosa SD; Ye C; Thabane L; Gafni A; Lok CE
    J Vasc Access; 2018 Mar; 19(2):146-152. PubMed ID: 28983900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of intrapleural pingyangmycin administration on activity of fibrinolytic system and transforming growth factor-beta1 in malignant pleural effusion].
    Zhu QQ; Sun GY
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Sep; 32(9):674-8. PubMed ID: 20079281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models.
    Komissarov AA; Florova G; Azghani AO; Buchanan A; Boren J; Allen T; Rahman NM; Koenig K; Chamiso M; Karandashova S; Henry J; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L389-99. PubMed ID: 27343192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.
    Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC
    Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.